» Articles » PMID: 36364289

Evidence of the Beneficial Effects of Ursolic Acid Against Lung Cancer

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2022 Nov 11
PMID 36364289
Authors
Affiliations
Soon will be listed here.
Abstract

Lung cancer is the leading cause of cancer-related deaths globally. Despite current treatment approaches that include surgery, chemotherapy, radiation and immunotherapies, lung cancer accounted for 1.79 million deaths worldwide in 2020, emphasizing the urgent need to find novel agents and approaches for more effective treatment. Traditionally, chemicals derived from plants, such as paclitaxel and docetaxel, have been used in cancer treatment, and in recent years, research has focused on finding other plant-derived chemicals that can be used in the fight against lung cancer. Ursolic acid is a polyphenol found in high concentrations in cranberries and other fruits and has been demonstrated to have anti-inflammatory, antioxidant and anticancer properties. In this review, we summarize recent research examining the effects of ursolic acid and its derivatives on lung cancer. Data from in vitro cell culture and in vivo animal studies show potent anticancer effects of ursolic acid and indicate the need for clinical studies.

Citing Articles

The Role of Pentacyclic Triterpenoids in Non-Small Cell Lung Cancer: The Mechanisms of Action and Therapeutic Potential.

Lee Y, Kwon R, Lee H, Chung J, Kim Y, Jeong H Pharmaceutics. 2025; 17(1).

PMID: 39861671 PMC: 11768946. DOI: 10.3390/pharmaceutics17010022.


Overview of Ursolic Acid Potential for the Treatment of Metabolic Disorders, Autoimmune Diseases, and Cancers via Nuclear Receptor Pathways.

Kadasah S, Radwan M Biomedicines. 2023; 11(10).

PMID: 37893218 PMC: 10604592. DOI: 10.3390/biomedicines11102845.


Ursolic Acid against Prostate and Urogenital Cancers: A Review of In Vitro and In Vivo Studies.

Kornel A, Nadile M, Retsidou M, Sakellakis M, Gioti K, Beloukas A Int J Mol Sci. 2023; 24(8).

PMID: 37108576 PMC: 10138876. DOI: 10.3390/ijms24087414.


Ursolic Acid Analogs as Potential Therapeutics for Cancer.

Panda S, Thangaraju M, Lokeshwar B Molecules. 2022; 27(24).

PMID: 36558113 PMC: 9785537. DOI: 10.3390/molecules27248981.

References
1.
Passaro A, Brahmer J, Antonia S, Mok T, Peters S . Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel Strategies. J Clin Oncol. 2022; 40(6):598-610. DOI: 10.1200/JCO.21.01845. View

2.
Mlala S, Oyedeji A, Gondwe M, Oyedeji O . Ursolic Acid and Its Derivatives as Bioactive Agents. Molecules. 2019; 24(15). PMC: 6695944. DOI: 10.3390/molecules24152751. View

3.
Guertin D, Sabatini D . Defining the role of mTOR in cancer. Cancer Cell. 2007; 12(1):9-22. DOI: 10.1016/j.ccr.2007.05.008. View

4.
Nooreldeen R, Bach H . Current and Future Development in Lung Cancer Diagnosis. Int J Mol Sci. 2021; 22(16). PMC: 8395394. DOI: 10.3390/ijms22168661. View

5.
Lin Y, Liang W, Chen C, Tsang H, Chiou J, Liu X . Network analysis and mechanisms of action of Chinese herb-related natural compounds in lung cancer cells. Phytomedicine. 2019; 58:152893. DOI: 10.1016/j.phymed.2019.152893. View